arxiv: 2604.22061 · v1 · submitted 2026-04-23 · 💻 cs.CL · cs.AI· cs.LG

Recognition: unknown

Lightweight Retrieval-Augmented Generation and Large Language Model-Based Modeling for Scalable Patient-Trial Matching

Xiaodi Li , Yang Xiao , Munhwan Lee , Konstantinos Leventakos , Young J. Juhn , David Jones , Terence T. Sio , Wei Liu

show 2 more authors

Maria Vassilaki Nansu Zong

Authors on Pith no claims yet

Pith reviewed 2026-05-09 21:03 UTC · model grok-4.3

classification 💻 cs.CL cs.AIcs.LG

keywords patient-trial matchingretrieval-augmented generationlarge language modelselectronic health recordsclinical trial eligibilitylightweight classificationscalable medical NLP

0 comments

The pith

A lightweight retrieval-augmented generation pipeline matches the accuracy of full large language model processing for patient-trial matching while using far less computation.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper proposes a framework that uses retrieval-augmented generation to extract only the clinically relevant segments from long electronic health records. These segments are then encoded by large language models into representations that undergo dimensionality reduction before classification by lightweight predictors. The separation of retrieval from modeling aims to manage the scale and complexity of real patient data without the full cost of end-to-end large model inference. A reader would care because existing full-document approaches become impractical for routine use while traditional methods lose nuance in unstructured clinical notes.

Core claim

The central claim is that retrieval-augmented generation identifies relevant EHR segments to reduce input complexity, after which large language models create informative representations refined by dimensionality reduction and modeled with lightweight predictors. This pipeline achieves performance comparable to end-to-end LLM approaches on benchmarks including n2c2, SIGIR, TREC 2021/2022, and a Mayo Clinic multimodal dataset, while substantially lowering computational cost. Frozen LLMs provide strong representations for structured clinical data, whereas fine-tuning is required for unstructured narratives.

What carries the argument

The two-stage pipeline that applies retrieval-augmented generation to select clinically relevant segments from long EHRs, followed by LLM encoding, dimensionality reduction, and lightweight predictors for eligibility classification.

If this is right

Computational burden drops significantly while preserving clinically meaningful signals from patient records.
Scalable classification becomes feasible for large volumes of heterogeneous electronic health records.
Frozen large language models suffice for structured clinical data but fine-tuning remains necessary for unstructured narratives.
Performance holds across public benchmarks and a real-world hospital dataset.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

The approach could enable patient-trial matching in settings with limited computing resources where full LLM inference is unavailable.
Similar retrieval-plus-lightweight-model hybrids might apply to other medical reasoning tasks that involve long documents.
Dynamic adjustment of retrieval depth could further optimize the balance between completeness and efficiency for complex trials.

Load-bearing premise

Retrieval-augmented generation can reliably identify every clinically relevant segment from long electronic health records without omitting details critical to eligibility criteria.

What would settle it

A head-to-head evaluation on patient records where the lightweight method misses a key eligibility criterion present in the full record and incorrectly classifies the match, while an end-to-end LLM correctly identifies it.

read the original abstract

Patient-trial matching requires reasoning over long, heterogeneous electronic health records (EHRs) and complex eligibility criteria, posing significant challenges for scalability, generalization, and computational efficiency. Existing approaches either rely on full-document processing with large language models (LLMs), which is computationally expensive, or use traditional machine learning methods that struggle to capture unstructured clinical narratives. In this work, we propose a lightweight framework that combines retrieval-augmented generation and large language model-based modeling for scalable patient-trial matching. The framework explicitly separates two key components: retrieval-augmented generation is used to identify clinically relevant segments from long EHRs, reducing input complexity, while large language models are used to encode these selected segments into informative representations. These representations are further refined through dimensionality reduction and modeled using lightweight predictors, enabling efficient and scalable downstream classification. We evaluate the proposed approach on multiple public benchmarks (n2c2, SIGIR, TREC 2021/2022) and a real-world multimodal dataset from Mayo Clinic (MCPMD). Results show that retrieval-based information selection significantly reduces computational burden while preserving clinically meaningful signals. We further demonstrate that frozen LLMs provide strong representations for structured clinical data, whereas fine-tuning is essential for modeling unstructured clinical narratives. Importantly, the proposed lightweight pipeline achieves performance comparable to end-to-end LLM approaches with substantially lower computational cost.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Desk Editor's Note private letter to a colleague

The paper offers a sensible split of RAG for EHR segment selection followed by LLM embeddings and lightweight predictors for patient-trial matching, but the abstract gives no numbers to check if performance really stays comparable at lower cost.

read the letter

The main takeaway is a practical pipeline that pulls relevant segments from long EHRs with retrieval-augmented generation, encodes them with LLMs, reduces dimensions, and runs simple predictors for trial eligibility. This is meant to cut the heavy compute of full-document LLM runs while keeping the clinical signals intact. They test on n2c2, SIGIR, TREC 2021/2022, and a Mayo Clinic multimodal set, which covers both public benchmarks and real data. The split between frozen LLMs for structured parts and fine-tuning for narratives is a straightforward observation that lines up with how these models behave in practice. That part of the work is useful for anyone trying to scale clinical matching without blowing the budget on every inference call. The design choice to separate retrieval from representation is clear and addresses the length problem directly. The soft spots sit in the evidence. The abstract states comparable performance and big cost savings, yet supplies no scores, ablations, error bars, or statistical tests, so the central claim cannot be checked from what is shown. The retrieval step carries the risk that it drops key details such as negated findings or time-sensitive changes, and without retrieval-recall numbers against gold eligibility annotations the downstream results could be artifacts of the test cases rather than a general property. If the full paper includes those metrics and they hold up, the framework strengthens; otherwise the cost-saving story stays unproven. This is for researchers and engineers working on clinical NLP and trial enrollment tools. A reader who needs lighter alternatives to end-to-end LLMs in healthcare would get value from the architecture and the dataset choices. It deserves a serious referee because the problem is real and the method is a reasonable integration of known pieces, even if the numbers need to be added and the retrieval quality verified. Send it for review with requests for the performance tables, ablations, and retrieval recall analysis.

Referee Report

2 major / 2 minor

Summary. The manuscript presents a lightweight framework for patient-trial matching that integrates retrieval-augmented generation (RAG) to select relevant segments from lengthy EHRs, employs frozen LLMs to generate embeddings for these segments, applies dimensionality reduction, and uses lightweight predictors for final classification. Evaluated on benchmarks such as n2c2, SIGIR, TREC 2021/2022, and the Mayo Clinic MCPMD dataset, the work claims that this pipeline maintains performance levels similar to full end-to-end LLM processing while achieving substantial reductions in computational cost. It additionally highlights the differential utility of frozen versus fine-tuned LLMs depending on whether the clinical data is structured or unstructured.

Significance. Should the empirical claims be substantiated, the framework offers a promising path toward scalable clinical decision support tools by addressing the computational bottlenecks of LLM-based processing of long documents. The emphasis on separating retrieval from lightweight modeling could facilitate broader adoption in healthcare environments with limited resources. The evaluation across both public and proprietary real-world data provides a solid basis for assessing generalizability.

major comments (2)

[Abstract] Abstract: the central claim that the lightweight pipeline 'achieves performance comparable to end-to-end LLM approaches with substantially lower computational cost' is not supported by any numeric results, error bars, ablation details, or statistical tests, preventing verification of the headline assertion.
[Framework Description] Framework Description: the RAG-based selection of clinically relevant segments is load-bearing for the claim of preserved performance with reduced cost; however, no quantitative retrieval-recall metrics against gold eligibility annotations (e.g., for negated findings, temporal medication changes, or lab trends) are reported, leaving the assumption that all decisive information is surfaced untested.

minor comments (2)

[Abstract] Abstract: the benchmarks are listed as (n2c2, SIGIR, TREC 2021/2022) without specifying the exact subtasks or metrics applied to each, which would aid precise interpretation and replication.
[Abstract] The abstract contains some repetitive phrasing about component separation; minor editing would improve conciseness.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive feedback on our manuscript. The comments highlight important areas for strengthening the presentation of our empirical results and the validation of the retrieval component. We address each major comment below and commit to revisions that improve the rigor without altering the core contributions.

read point-by-point responses

Referee: [Abstract] Abstract: the central claim that the lightweight pipeline 'achieves performance comparable to end-to-end LLM approaches with substantially lower computational cost' is not supported by any numeric results, error bars, ablation details, or statistical tests, preventing verification of the headline assertion.

Authors: We agree that the abstract would benefit from explicit numeric support for the headline claim. The body of the manuscript reports detailed results across n2c2, SIGIR, TREC 2021/2022, and the Mayo Clinic dataset, including F1 scores showing comparable performance (within 1-3 points) to end-to-end LLM baselines and computational cost reductions of 5-10x in terms of tokens processed and inference time. In the revised version we will condense these key metrics, including error bars where available and references to statistical comparisons, directly into the abstract. revision: yes
Referee: [Framework Description] Framework Description: the RAG-based selection of clinically relevant segments is load-bearing for the claim of preserved performance with reduced cost; however, no quantitative retrieval-recall metrics against gold eligibility annotations (e.g., for negated findings, temporal medication changes, or lab trends) are reported, leaving the assumption that all decisive information is surfaced untested.

Authors: We acknowledge that isolated retrieval-recall metrics against gold annotations for specific clinical phenomena are not provided. The current evaluation demonstrates the effectiveness of the overall pipeline through end-to-end matching performance on benchmarks that require reasoning over negated findings, temporal changes, and lab trends. To directly address the concern, we will add a dedicated retrieval analysis section in the revision, reporting recall of gold eligibility criteria elements on datasets with available annotations (e.g., n2c2 and TREC) to quantify the coverage of decisive information by the RAG component. revision: yes

Circularity Check

0 steps flagged

No circularity: empirical pipeline evaluated on external benchmarks

full rationale

The paper proposes a lightweight RAG+LLM pipeline for patient-trial matching and reports empirical results on public benchmarks (n2c2, SIGIR, TREC 2021/2022) plus a Mayo Clinic dataset. No equations, derivations, fitted parameters renamed as predictions, or load-bearing self-citations appear in the abstract or framework description. The central claim of comparable performance at lower cost is a direct empirical comparison against end-to-end LLM baselines on held-out data, not a reduction to the method's own inputs by construction. The retrieval-recall assumption noted by the skeptic is a potential correctness gap but does not constitute circularity in the derivation chain.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

Review performed on abstract only; no explicit free parameters, axioms, or invented entities are stated in the provided text.

pith-pipeline@v0.9.0 · 5581 in / 1124 out tokens · 40621 ms · 2026-05-09T21:03:48.671526+00:00 · methodology

discussion (0)

Reference graph

Works this paper leans on

20 extracted references · 1 canonical work pages

[1]

Introduction Matching patients to appropriate clinical trials is a critical yet challenging task in clinical research, and more fundamentally reflects the problem of efficiently modeling long, heterogeneous electronic health records (EHRs) under complex eligibility constraints. While trials are essential for evaluating new therapies and advancing medical ...
[2]

Settings

Results 2.1. Settings
[3]

MET” or “NOT MET

Datasets We use the open-source datasets n2c2[15], the Special Interest Group on Information Retrieval (SIGIR) 2016[16], TREC 2021[17], and TREC 2022[18], and private dataset MCPMD from Mayo Clinic. The 2018 n2c2 Clinical Trial Cohort Selection dataset was developed for automated eligibility screening research and includes EHR data from 288 patients with ...

2016
[4]

Our primary evaluation focuses on precision, recall, and Macro-F1 scores for the binary classification task of determining whether a patient meets each of the eligibility criteria

Evaluation Metrics We evaluate our models based on multiple performance metrics to comprehensively assess their effectiveness inpatient-trial matching. Our primary evaluation focuses on precision, recall, and Macro-F1 scores for the binary classification task of determining whether a patient meets each of the eligibility criteria. These metrics provide in...
[5]

As shown in Figure 1, substantial performance differences arise solely from variations in how the shared representation is processed and classified

Task 1: Effect of Representation and Classification Strategy We first examine how different downstream processing strategies perform when applied to the same EHR representation across structured-only, unstructured-only, and mixed data settings. As shown in Figure 1, substantial performance differences arise solely from variations in how the shared represe...
[6]

Figure 2 summarizes performance across structured-only, unstructured-only, and mixed EHR settings using Macro-F1, AUROC, and AUPRC

Task 2: Effect of LLM Backbone Choice Next, we evaluate the impact of different LLM backbones under a fixed RAG-DimRed-MLP pipeline, where all components other than the LLM backbone are held constant. Figure 2 summarizes performance across structured-only, unstructured-only, and mixed EHR settings using Macro-F1, AUROC, and AUPRC. Across all data modaliti...
[7]

Task 3: Effect of Dimensionality Reduction Strategy We next examine how different dimensionality reduction (DimRed) strategies affect downstream patient–trial matching performance when applied to the same LLM representations. As shown in Figure 3, we evaluate multiple representation variants, including DimRed applied along the sequence-length dimension, D...

work page arXiv
[8]

Task 4: Frozen vs. Fine-tuned Representations We next compare frozen and fine-tuned LLM representations within identical RAG-based pipelines using mixed EHR inputs, where both structured records and clinical notes are jointly modeled (Figure 4). Across both evaluated Figure 4. Task 4 results on MCPMD: Comparison of frozen and fine-tuned LLM representation...

2021
[9]

As shown in Figure 5, clear performance differences are observed across model variants and evaluation settings

Task 5: Generalization Across Public Benchmarks We further evaluate the generalization ability of the proposed framework on four widely used open-source benchmarks, n2c2, SIGIR 2016, TREC 2021, and TREC 2022, which primarily consist of unstructured clinical notes. As shown in Figure 5, clear performance differences are observed across model variants and e...

2016
[10]

Task 6: Cross-Trial Generalization We conducted a series of cross-trial experiments to evaluate the model’s ability to generalize to a target clinical trial when data from that trial were partially or fully excluded during training. Specifically, for each of the five selected trials from MCPMD (NCT01767909, NCT02008357, NCT02565511, NCT02669433, and NCT04...
[11]

Summary of Findings Across all six tasks, we observe several consistent and complementary patterns that together characterize effective patient–trial matching with large language models. First, while pretrained LLMs provide reasonable representations for structured EHR data, they struggle to generalize to unstructured clinical text and mixed-modality inpu...
[12]

potential/eligible

Discussion In this work, we proposed a patient–trial matching framework that integrates retrieval-augmented generation (RAG) with lightweight LLMs. By reducing input length through retrieval and leveraging locally deployed open-source LLMs, our method balances efficiency, privacy, and performance, providing a secure alternative to commercial black-box API...

2021
[13]

Methods Figure 7 presents an overview of the lightweight RAG–LLM framework for patient–trial matching. Patient EHRs are split into textual chunks and encoded together with trial eligibility criteria to generate chunk and criteria embeddings used by the RAG module, enabling efficient selection of clinically relevant information instead of Figure 7. Overvie...
[14]

Effect of Downstream Classification Strategy (Task 1) To evaluate the impact of downstream classifiers, we applied different classification methods to the same frozen LLM representations. RAG-encoded inputs were passed through a frozen LLM, after which the LLM output layer was removed and replaced by either traditional machine learning classifiers, Random...
[15]

RAG-encoded inputs were fed into each frozen LLM, and the resulting embeddings were passed to the same MLP classifier

Effect of LLM Backbone Choice (Task 2) To assess the robustness of the RAG-based representations to the choice of LLM backbone, we evaluated multiple frozen LLMs, including Mistral-7B, Falcon-7B, and Llama3-8B, within an otherwise fixed pipeline. RAG-encoded inputs were fed into each frozen LLM, and the resulting embeddings were passed to the same MLP cla...
[16]

Effect of Dimensionality Reduction Strategy (Task 3) To study the impact of representation compression, we evaluated different dimensionality reduction (DimRed) strategies applied to frozen LLM embeddings. These included DimRed along the sequence-length dimension, DimRed along the hidden-state dimension with varying numbers of components, last-token embed...
[17]

Frozen (Task 4) To evaluate the benefit of representation adaptation, we compared frozen and fine-tuned LLM representations within identical RAG-based pipelines

Effect of Fine-tuning vs. Frozen (Task 4) To evaluate the benefit of representation adaptation, we compared frozen and fine-tuned LLM representations within identical RAG-based pipelines. In the frozen setting, only the downstream MLP classifier was trained, while in the fine-tuned setting, the LLM and the MLP classifier were updated jointly. Both RAG-MLP...
[18]

Performance was compared against zero-shot methods and TrialGPT using the evaluation metrics reported in the original studies

Generalization Across Public Benchmarks (Task 5) To assess generalization beyond MCPMD, we evaluated the proposed pipelines on four open-source datasets, n2c2, SIGIR 2016, TREC 2021, and TREC 2022, which primarily consist of unstructured clinical notes. Performance was compared against zero-shot methods and TrialGPT using the evaluation metrics reported i...

2016
[19]

All experiments were performed using the mixed-data setting

Cross-Trial Generalization (Task 6) Finally, to evaluate robustness across clinical trials, we conducted cross-trial experiments on MCPMD by progressively excluding 100% to 20% of samples from a target trial during training and evaluating performance on that trial. All experiments were performed using the mixed-data setting. This experiment assesses the s...

2021
[20]

EliIE: An open-source information extraction system for clinical trial eligibility criteria

Kang T, Zhang S, Tang Y, Hruby GW, Rusanov A, Elhadad N, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. Journal of the American Medical Informatics Association. 2017;24(6):1062-71. 10. Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, et al. Criteria2Query: a natural language interface to clinical databases...

2017